Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1997-08-05
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514114, 514252, 544354, 544337, 544230, 544295, C07D24144, C07D24152, C07D24154, A61K 31495
Patent
active
056543034
ABSTRACT:
A novel series of substituted quinoxaline 2,3-diones useful as neuroprotective agents are taught. Novel intermediates, processes of preparation, and pharmaceutical compositions containing the compounds are also taught. The compounds are glutamate antagonists and are useful in the treatment of stroke, cerebral ischemia, or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, status epilepticus, perinatal asphyxia, anoxia, Alzheimer's, Parkinson's, and Huntington's diseases.
REFERENCES:
patent: 3992378 (1976-11-01), St. Clair et al.
Copending USSN 08/124,770 (Sep. 1993).
Copending USSN 08/404,400 (Mar. 1995).
Kostic, S. et al. Bioorg. Med. Chem. Lett. 1, 403-406 (1991).
Raines, A. Basic Pharmacology in Medicine (Medical Surveillance Inc., West Chester), ed. by DiPalma, J.R. et al., pp. 314-315 (1994).
Kornberg Brian Edward
Nikam Sham
Rafferty Michael Francis
Anderson Elizabeth M.
Grumbling Matthew V.
Warner-Lambert & Company
Wong King Lit
LandOfFree
Alkyl amine derivatives of substituted quinoxaline 2,3-diones as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl amine derivatives of substituted quinoxaline 2,3-diones as, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl amine derivatives of substituted quinoxaline 2,3-diones as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075010